Profitelligence Profitelligence · Filing Ledger Open TMO research →

Form 8-K · Current Report · Filed 2026-05-26

Thermo Fisher Scientific Elects New Board Members and Receives Advisory Vote Results

At the Annual Meeting held on May 20, 2026, Thermo Fisher Scientific's shareholders elected ten new members to the Company's Board of Directors.

Filer
Thermo Fisher Scientific Inc. TMO · NYSE
Filed
Accession
0000097745-26-000117
CIK
0000097745
Signal
Medium impactHealthcare

Details

The non-binding, advisory proposal on the compensation of the Company's named executive officers was not approved. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified.

Items reported

Item events

Reported Item

Board Member Appointed Say-on-Pay Failed

Market reaction

Close before filing

$448.28

Next session

+1.8%

Since filing

+28.1%

Latest close

$574.30

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from TMO reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, TMO insiders reported 16 Form 4 transactions — net selling of $36K.

Full TMO insider history →

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another TMO filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts